These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 15767558)
1. The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15. Kim JS; Baek SJ; Sali T; Eling TE Mol Cancer Ther; 2005 Mar; 4(3):487-93. PubMed ID: 15767558 [TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene. Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062 [TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Jang TJ; Kang HJ; Kim JR; Yang CH Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942 [TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells. Liggett JL; Choi CK; Donnell RL; Kihm KD; Kim JS; Min KW; Noegel AA; Baek SJ Biochim Biophys Acta; 2014 Jan; 1840(1):322-31. PubMed ID: 24080406 [TBL] [Abstract][Full Text] [Related]
5. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817 [TBL] [Abstract][Full Text] [Related]
6. The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1/MIC-1/PTGF-beta). Yang H; Park SH; Choi HJ; Moon Y Carcinogenesis; 2010 Apr; 31(4):703-11. PubMed ID: 20130018 [TBL] [Abstract][Full Text] [Related]
7. The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells. Kambe A; Yoshioka H; Kamitani H; Watanabe T; Baek SJ; Eling TE Cancer Prev Res (Phila); 2009 Dec; 2(12):1088-99. PubMed ID: 19934343 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells. Moon Y; Yang H; Kim YB Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376 [TBL] [Abstract][Full Text] [Related]
10. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198 [TBL] [Abstract][Full Text] [Related]
11. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac. Wang X; Kingsley PJ; Marnett LJ; Eling TE Cancer Prev Res (Phila); 2011 Jan; 4(1):150-60. PubMed ID: 21205743 [TBL] [Abstract][Full Text] [Related]
12. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury. Chiou SK; Hoa N; Hodges A Biochem Pharmacol; 2011 Jun; 81(11):1317-23. PubMed ID: 21458423 [TBL] [Abstract][Full Text] [Related]
13. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866 [TBL] [Abstract][Full Text] [Related]
14. Proapoptotic activity of NAG-1 is cell type specific and not related to COX-2 expression. Jang TJ; Kim NI; Lee CH Apoptosis; 2006 Jul; 11(7):1131-8. PubMed ID: 16699947 [TBL] [Abstract][Full Text] [Related]
16. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225 [TBL] [Abstract][Full Text] [Related]
17. A novel anticancer effect of Astragalus saponins: Transcriptional activation of NSAID-activated gene. Auyeung KK; Cho CH; Ko JK Int J Cancer; 2009 Sep; 125(5):1082-91. PubMed ID: 19384947 [TBL] [Abstract][Full Text] [Related]
18. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. Zerbini LF; Tamura RE; Correa RG; Czibere A; Cordeiro J; Bhasin M; Simabuco FM; Wang Y; Gu X; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA PLoS One; 2011; 6(9):e24285. PubMed ID: 21931671 [TBL] [Abstract][Full Text] [Related]
19. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Moon Y; Bottone FG; McEntee MF; Eling TE Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405 [TBL] [Abstract][Full Text] [Related]
20. Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer. Jang TJ; Jung KH; Choi EA Int J Cancer; 2006 Mar; 118(6):1356-63. PubMed ID: 16184548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]